The content on this site is intended for healthcare professionals only
Prof Ludwig talks to ecancertv at ICMM 2016 about treating elderly patients based on their biological rather than chronological age.
He argues that types and dose levels of treatments should be administered based on a patient's specific state of health and fitness, rather than discriminatory assumptions based on age-related stereotypes.
Prof Ludwig also stresses the importance of patients being more assertive and involving themselves more in treatment decisions, with the support of family and friends where possible.
ecancer's filming at ICMM 2016 has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Grand Rounds: Improving quality of patient-centred care
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
OncoAlert Round Up for September 15-21, 2023
Potential benefit to response rates from trastuzumab added to perioperative chemotherapy for patients with HER-2+ GC
Selinexor, bortezomib and dexamethasone shows PFS benefit for multiple myeloma
ADCLEC.syn1 and CD33-CARS in humanised acute myeloid leukaemia models shows promising efficacy
